InvestSMART

Aroa Biosurgery Limited (ASX: ARX) - Announcements

Current share price for ARX : $0.490 0.01 (2.08%)+

ASX company news and announcements for Aroa Biosurgery Limited (ARX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Aroa Biosurgery Limited (ARX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Aroa Biosurgery Limited (ARX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Aroa Biosurgery Limited (ARX)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$169 June Quarterly Report and Appendix 4C 16 Jul 2021 9:53AM $1.230 $0.490 fallen by 60.16%
$169 Notification of cessation of securities - ARX 7 Jul 2021 4:00PM $1.225 $0.490 fallen by 60%
$169 Notification regarding unquoted securities - ARX 7 Jul 2021 3:11PM $1.230 $0.490 fallen by 60.16%
$169 Appendix 3G 7 Jul 2021 2:41PM $1.230 $0.490 fallen by 60.16%
$169 Investor Day Presentation 5 Jul 2021 8:27AM $1.130 $0.490 fallen by 56.64%
$169 Investor Day - 5 July 2 Jul 2021 9:49AM $1.100 $0.490 fallen by 55.45%
$169 Notice of Annual General Meeting/Proxy Form 1 Jul 2021 12:01PM $1.120 $0.490 fallen by 56.25%
$169 Appendix 4G and Corporate Governance Statement 22 Jun 2021 8:57AM $1.025 $0.490 fallen by 52.20%
$169 Annual Report to Shareholders 22 Jun 2021 8:52AM $1.025 $0.490 fallen by 52.20%
$169 Change of Director's Interest Notice - PM 11 Jun 2021 3:56PM $1.080 $0.490 fallen by 54.63%
$169 Application for quotation of securities - ARX 11 Jun 2021 3:53PM $1.080 $0.490 fallen by 54.63%
$169 Application for quotation of securities - ARX 11 Jun 2021 3:47PM $1.083 $0.490 fallen by 54.73%
$169 Section 708A Cleansing Statement 11 Jun 2021 3:43PM $1.083 $0.490 fallen by 54.73%
$169 FY21 Full Year Results Presentation 25 May 2021 9:09AM $1.180 $0.490 fallen by 58.47%
$169 Preliminary Final Report 25 May 2021 9:09AM $1.180 $0.490 fallen by 58.47%
$169 Notice of AGM Date and Director Nomination Closing Date 24 May 2021 2:01PM $1.170 $0.490 fallen by 58.12%
$169 Aroa Biosurgery Full Year Results Webinar 21 May 2021 9:56AM $1.130 $0.490 fallen by 56.64%
$169 Appendix 3G 4 May 2021 10:01AM $1.140 $0.490 fallen by 57.02%
$169 Quarterly Results Webinar 28 Apr 2021 8:52AM $1.160 $0.490 fallen by 57.76%
$169 March Quarterly Report and Appendix 4C 28 Apr 2021 8:51AM $1.160 $0.490 fallen by 57.76%
$169 Change of Registered Office 21 Apr 2021 1:08PM $1.140 $0.490 fallen by 57.02%
$169 Aroa secures FDA clearance for new product 6 Apr 2021 9:00AM $1.140 $0.490 fallen by 57.02%
$169 Aroa to present at NWR Virtual Investor Conference 17 Mar 2021 3:39PM $1.200 $0.490 fallen by 59.17%
$169 S&P DJI Announces March 2021 Quarterly Rebalance 12 Mar 2021 5:02PM $1.200 $0.490 fallen by 59.17%
$169 Change of Director's Interest Notice - JD 23 Feb 2021 3:05PM $1.235 $0.490 fallen by 60.32%

301 - 325 of 777 results

Page 13 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.